Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mycophenolate Mofetil to Overcome Glioblastoma Resistance to Radiotherapy and Temozolomide

NCT07605364 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT07605364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mycophenolate Mofetil to Overcome Glioblastoma Resistance to Radiotherapy and Temozolomide
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
June 10, 2026
Completion date
January 5, 2031
Enrollment
422 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced glioblastoma